A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

December 18, 2014

Primary Completion Date

April 9, 2020

Study Completion Date

April 9, 2020

Conditions
Fibrodysplasia Ossificans Progressiva
Trial Locations (7)

4102

Queensland University of Technology (QUT) Institute of Health and Biomedical Innovation (IHBI), Woolloongabba

19104

University of Pennsylvania, Center for FOP & Related Bone Disorders, Philadelphia

94143

University of California San Francisco, Division of Endocrinology and Metabolism, San Francisco

Unknown

Hospital Italiano de Buenos Aires, Department of Pediatrics, Buenos Aires

Hôpital Necker-Enfants Malades, Department of Genetics, Paris

Gaslini Institute, Unit of Rare Diseases, Department of Pediatrics, Genoa

HA7 4LP

The Royal National Orthopaedic Hospital, Brockley Hill, Stanmore

Sponsors
All Listed Sponsors
lead

Clementia Pharmaceuticals Inc.

INDUSTRY